Resolvins, docosatrienes, and neuroprotectins, novel omega-3-derived mediators, and their aspirin-triggered endogenous epimers: An overview of their protective roles in catabasis

Prostaglandins and Other Lipid Mediators

Volumn 73, Issue 3-4, 2004, Pages 155-172

  Serhan, Charles N ^a   Gotlinger, Katherine ^a   Hong, Song ^a   Arita, Makoto ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Bioactive lipids; Essential fatty acids; Fish oils; Inflammation; Neutrophils; Omega 3; Resolution

Indexed keywords

ACETYLSALICYLIC ACID; ANTIINFLAMMATORY AGENT; OMEGA 3 FATTY ACID; VASCULOTROPIN;

ANTIINFLAMMATORY ACTIVITY; BIOSYNTHESIS; CHEMICAL STRUCTURE; CONJUGATION; DRUG POTENCY; IMMUNOREGULATION; INFLAMMATION; NONHUMAN; REVIEW;

ANIMALS; ANTI-INFLAMMATORY AGENTS; ASPIRIN; DOCOSAHEXAENOIC ACIDS; EICOSAPENTAENOIC ACID; FATTY ACIDS, OMEGA-3; HUMANS; INFLAMMATION;

EID: 2942545915     PISSN: 10988823     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.prostaglandins.2004.03.005     Document Type: Review

References (55)

1. Serhan C.N., Clish C.B., Brannon J., Colgan S.P., Chiang N., Gronert K. Novel functional sets of lipid-derived mediators with antiinflammatory actions generated from omega-3 fatty acids via cyclooxygenase 2-nonsteroidal antiinflammatory drugs and transcellular processing. J. Exp. Med. 192:2000;1197
2. Serhan C.N., Hong S., Gronert K., et al. Resolvins: a family of bioactive products of omega-3 fatty acid transformation circuits initiated by aspirin treatment that counter pro-inflammation signals. J. Exp. Med. 196:2002;1025
3. Hong S., Gronert K., Devchand P., Moussignac R.-L., Serhan C.N. Novel docosatrienes and 17S-resolvins generated from docosahexaenoic acid in murine brain, human blood and glial cells: autacoids in anti-inflammation. J. Biol. Chem. 278:2003;14677
4. Marcheselli V.L., Hong S., Lukiw W.J., et al. Novel docosanoids inhibit brain ischemia-reperfusion-mediated leukocyte infiltration and pro-inflammatory gene expression. J. Biol. Chem. 278:2003;43807
5. Mukherjee PK, Marcheselli VL, Serhan CN, Bazan NG. Neuroprotectin D1: a docosahexaenoic acid-derived docosatriene protects human retinal pigment epithelial cells from oxidative stress. Proc Natl Acad Sci USA [submitted for publication].
6. Burr G.O., Burr M.M. A new deficiency disease produced by the rigid exclusion of fat from the diet. J. Biol. Chem. 82:1929;345
7. Lands WEM, editor. Proceedings of the AOCS Short Course on Polyunsaturated Fatty Acids and Eicosanoids. Champaign, IL: American Oil Chemists' Society; 1987.
8. Bazan NG. 1990. Supply of n - 3 polyunsaturated fatty acids and their significance in the central nervous system. In: Wurtman RJ, Wurtman JJ, editors. Nutrition and the brain. New York: Raven Press. p. 1.
9. Simopoulos A.P., Leaf A., Salem N. Jr. Workshop on the essentiality of and recommended dietary intakes for omega-6 and omega-3 fatty acids. J. Am. Coll. Nutr. 18:1999;487
10. Salem N. Jr., Litman B., Kim H.-Y., Gawrisch K. Mechanisms of action of docosahexaenoic acid in the nervous system. Lipids. 36:2001;945
11. Helgadottir A., Manolescu A., Thorleifsson G., et al. The gene encoding 5-lipoxygenase activating protein confers risk of myocardial infarction and stroke. Nat. Genet. 36:2004;233
12. Erlinger T.P., Platz E.A., Rifai N., Helzlsouer K.J. C-reactive protein and the risk of incident colorectal cancer. JAMA. 291:2004;585
13. Pasche B., Serhan C.N. Is C-reactive protein an inflammation opsonin that signals colon cancer risk? JAMA. 291:2004;623
14. Gallin JI, Snyderman R, Fearon DT, Haynes BF, Nathan C, editors. Inflammation: basic principles and clinical correlates. Philadelphia: Lippincott Williams & Wilkins; 1999.
15. Van Dyke T.E., Serhan C.N. Resolution of inflammation: a new paradigm for the pathogenesis of periodontal diseases. J. Dent. Res. 82:2003;82
16. Lehr H.-A., Olofsson A.M., Carew T.E., et al. P-selectin mediates the interaction of circulating leukocytes with platelets and microvascular endothelium in response to oxidized lipoprotein in vivo. Lab. Invest. 71:1994;380
17. Mora J.R., Bono M.R., Manjunath N., et al. Selective imprinting of gut-homing T cells by Peyer's patch dendritic cells. Nature. 424:2003;88
18. Serhan C.N., Hamberg M., Samuelsson B. Lipoxins: novel series of biologically active compounds formed from arachidonic acid in human leukocytes. Proc. Natl. Acad. Sci. USA. 81:1984;5335
19. 4 by platelet 12-lipoxygenase in vitro. J. Clin. Invest. 85:1990;772
20. Marcus AJ. Platelets: their role in hemostasis, thrombosis, and inflammation. In: Gallin JI, Snyderman R, editors. Inflammation: basic principles and clinical correlates. Philadelphia: Lippincott Williams & Wilkins; 1999. p. 77.
21. 4 with human neutrophils. J. Biol. Chem. 267:1992;16168
22. 4 receptor. J. Exp. Med. 180:1994;253
23. 4 in human neutrophils. Mol. Pharmacol. 63:2003;721
24. 4 analogs attenuate induction of intestinal epithelial proinflammatory gene expression and reduce the severity of dextran sodium sulfate-induced colitis. J. Immunol. 168:2002;5260
25. 4 are potent stimuli for human monocyte migration and adhesion: selective inactivation by dehydrogenation and reduction. J. Exp. Med. 183:1996;137
26. Godson C, Mitchell S., Harvey K., Petasis N.A., Hogg N., Brady H.R. Cutting edge: lipoxins rapidly stimulate nonphlogistic phagocytosis of apoptotic neutrophils by monocyte-derived macrophages. J. Immunol. 164:2000;1663
27. Clária J., Serhan C.N. Aspirin triggers previously undescribed bioactive eicosanoids by human endothelial cell-leukocyte interactions. Proc. Natl. Acad. Sci USA. 92:1995;9475
28. Perretti M., Chiang N., La M., et al. Endogenous lipid- and peptide-derived anti-inflammatory pathways generated with glucocorticoid and aspirin treatment activate the lipoxin A(4) receptor. Nat. Med. 8:2002;1296
29. Vane J.R. Back to an aspirin a day? Science. 296:2002;474
30. 2. Science. 296:2002;539
31. 4 inhibit human neutrophil migration: comparisons between synthetic 15 epimers in chemotaxis and transmigration with microvessel endothelial cells and epithelial cells. J. Immunol. 170:2003;2688
32. 4. J. Pharmacol. Exp. Ther. 300:2002;385
33. Kieran N.E., Doran P.P., Connolly S.B., et al. Modification of the transcriptomic response to renal ischemia/reperfusion injury by lipoxin analog. Kidney Int. 64:2003;480
34. Devchand P.R., Arita M., Hong S., et al. Human ALX receptor regulates neutrophil recruitment in transgenic mice: roles in inflammation and host-defense. FASEB J. 17:2003;652
35. Serhan C.N., Jain A., Marleau S., et al. Reduced inflammation and tissue damage in transgenic rabbits overexpressing 15-lipoxygenase and endogenous anti-inflammatory lipid mediators. J. Immunol. 171:2003;6856
36. Weissmann G., Smolen J.E., Korchak H.M. Release of inflammatory mediators from stimulated neutrophils. New Engl. J. Med. 303:1980;27
37. Samuelsson B. From studies of biochemical mechanisms to novel biological mediators: prostaglandin endoperoxides, thromboxanes and leukotrienes. In: Les Prix Nobel: Nobel Prizes, presentations, biographies and lectures. Stockholm: Almqvist & Wiksell; 1982. p. 153.
38. Vane JR. Adventures and excursions in bioassay: the stepping stones to prostacyclin. In: Les Prix Nobel: Nobel Prizes, presentations, biographies and lectures. Stockholm: Almqvist & Wiksell; 1982. p. 181.
39. GISSI-Prevenzione Investigators. Dietary supplementation with n - 3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial. Gruppo Italiano per lo Studio della Sopravvivenza neirinfarto miocardico. Lancet 1999;354(9177):447.
40. Marchioli R., Barzi F., Bomba E., et al. Early protection against sudden death by n - 3 polyunsaturated fatty acids after myocardial infarction: time-course analysis of the results of the Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico (GISSI)-Prevenzione. Circulation. 105:2002;1897
41. Rosenstein E.D., Kushner L.J., Kramer N., Kazandjian G. Pilot study of dietary fatty acid supplementation in the treatment of adult periodontitis. Prostaglandins Leukot. Essent. Fatty Acids. 68:2003;213
42. Bazan N.G. Supply, uptake, and utilization of docosahexaenoic acid during photoreceptor cell differentiation. Nestle Nutr. Workshop Ser. 28:1992;121
43. Hamberg M., Samuelsson B. On the specificity of the oxygenation of unsaturated fatty acids catalyzed by soybean lipoxidase. J. Biol. Chem. 242:1967;5329
44. Lee T.H., Mencia-Huerta J.-M., Shih C., Corey E.J., Lewis R.A., Austen K.F. Effects of exogenous arachidonic, eicosapentaenoic, and docosahexaenoic acids on the generation of 5-lipoxygenase pathway products by ionophore-activated human neutrophils. J. Clin. Invest. 74:1984;1922
45. Sawazaki S., Salem N. Jr., Kim H.-Y. Lipoxygenation of docosahexaenoic acid by the rat pineal body. J. Neurochem. 62:1994;2437
46. 4- neuroprostanes) in vivo from docosahexaenoic acid. Biochemistry. 39:2000;2376
47. Van Rollins M., Baker R.C., Sprecher H.W., Murphy R.C. Oxidation of docosahexaenoic acid by rat liver microsomes. J. Biol. Chem. 259:1984;5776
48. Lands W.E.M. Diets could prevent many diseases. Lipids. 38:2003;317
49. Winyard PG, Willoughby DA, editors. Inflammation protocols. Totowa, NJ: Humana Press; 2003.
50. Lu Y, Hong S, Tjonahen E, Serhan CN. Lipid mediator lipidomics: databases and search algorithms of electric spray ionization/tandem mass and ultraviolet spectra for structural elucidation. In: 5th Winter Eicosanoid Conference, Baltimore; 2003.
51. Arita M, Bianchini F, Aliberti J, et al. Novel omega-3 autacoid resolvin E1: receptor identification and anti-inflammatory properties. J Leukoc Biol 2003;(Suppl 31):72.
52. Corey E.J., Shih C., Cashman J.R. Docosahexaenoic acid is a strong inhibitor of prostaglandin but not leukotriene biosynthesis. Proc. Natl. Acad. Sci. USA. 80:1983;3581
53. Serhan C.N., Oliw E. Unorthodox routes to prostanoid formation: new twists in cyclooxygenase-initiated pathways. J. Clin. Invest. 107:2001;1481
54. Rowley A.F., Lloyd-Evans P., Barrow S.E., Serhan C.N. Lipoxin biosynthesis by trout macrophages involves the formation of epoxide intermediates. Biochemistry. 33:1994;856
55. Hamberg M., Sanz A., Rodriguez M.J., Calvo A.P., Castresana C. Activation of the fatty acid α-dioxygenase pathway during bacterial infection of tobacco leaves. J. Biol. Chem. 278:2003;51796